Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 133 participants.

Also called NCT01994941

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 133 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01994941
Other papers using this trial's data
  • Genotyping-guided approach versus the conventional approach in selection of oral P2Y12 receptor blockers in Chinese patients suffering from acute coronary syndrome The Journal of international medical research, 2017-02 DOI, PubMed 28222641, PMC5536604 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Hong Kong SAR China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01994941. Randomized; no masking; primary purpose treatment. Start 2013-08 (registry gives no type); primary completion 2015-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
Condition
Acute Coronary Syndrome
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Ticagrelor
Lead sponsor
The University of Hong Kong (class: other)

Record details

Record id
cardio:ct-nct01994941
Content hash
182296228eece99224d6dfcf2e6e8810672402fe0f6e70f7e57db4ba8ce43ca0